(Q40116643)

17 September 2017

Neurotropin demonstrates cytoprotective effects in lung cells through the induction of thioredoxin-1. (English)

1 reference

17 September 2017

Yuma Hoshino

1

1 reference

17 September 2017

Takayuki Nakamura

2

1 reference

17 September 2017

Atsuyasu Sato

3

1 reference

17 September 2017

Michiaki Mishima

4

1 reference

17 September 2017

Junji Yodoi

5

1 reference

17 September 2017

Hajime Nakamura

6

1 reference

17 September 2017

21 June 2007

1 reference

American Journal of Respiratory Cell and Molecular Biology

17 September 2017

1 reference

17 September 2017

37

1 reference

17 September 2017

4

1 reference

17 September 2017

438-446

1 reference

Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. Bethesda, Maryland, August 29-31, 1995.

17 September 2017

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Redox regulation of cellular activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Extracellular thioredoxin levels are increased in patients with acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Serum thioredoxin and alpha-tocopherol concentrations in patients with major risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Expression of thioredoxin in bleomycin-injured airway epithelium: possible role of protection against bleomycin induced epithelial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Oxidant and antioxidant balance in the airways and airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Alveolar wall apoptosis causes lung destruction and emphysematous changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Mechanisms of analgesic action of neurotropin on chronic pain in adjuvant-induced arthritic rat: roles of descending noradrenergic and serotonergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Genomic cloning of human thioredoxin-encoding gene: mapping of the transcription start point and analysis of the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

Systemic oxidative stress in asthma, COPD, and smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2006-0402OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2006-0402OC

1 reference

17 September 2017

1 reference